1. Home
  2. POCI vs GRCE Comparison

POCI vs GRCE Comparison

Compare POCI & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POCI
  • GRCE
  • Stock Information
  • Founded
  • POCI 1982
  • GRCE 2002
  • Country
  • POCI United States
  • GRCE United States
  • Employees
  • POCI N/A
  • GRCE N/A
  • Industry
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GRCE
  • Sector
  • POCI Health Care
  • GRCE
  • Exchange
  • POCI Nasdaq
  • GRCE NYSE
  • Market Cap
  • POCI 32.4M
  • GRCE 35.6M
  • IPO Year
  • POCI N/A
  • GRCE N/A
  • Fundamental
  • Price
  • POCI $4.91
  • GRCE $3.45
  • Analyst Decision
  • POCI
  • GRCE
  • Analyst Count
  • POCI 0
  • GRCE 0
  • Target Price
  • POCI N/A
  • GRCE N/A
  • AVG Volume (30 Days)
  • POCI 6.7K
  • GRCE 133.8K
  • Earning Date
  • POCI 02-13-2025
  • GRCE 02-13-2025
  • Dividend Yield
  • POCI N/A
  • GRCE N/A
  • EPS Growth
  • POCI N/A
  • GRCE N/A
  • EPS
  • POCI N/A
  • GRCE N/A
  • Revenue
  • POCI $18,980,148.00
  • GRCE N/A
  • Revenue This Year
  • POCI N/A
  • GRCE N/A
  • Revenue Next Year
  • POCI N/A
  • GRCE N/A
  • P/E Ratio
  • POCI N/A
  • GRCE N/A
  • Revenue Growth
  • POCI N/A
  • GRCE N/A
  • 52 Week Low
  • POCI $3.47
  • GRCE $2.13
  • 52 Week High
  • POCI $6.90
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • POCI 44.88
  • GRCE N/A
  • Support Level
  • POCI $4.75
  • GRCE N/A
  • Resistance Level
  • POCI $5.19
  • GRCE N/A
  • Average True Range (ATR)
  • POCI 0.22
  • GRCE 0.00
  • MACD
  • POCI -0.02
  • GRCE 0.00
  • Stochastic Oscillator
  • POCI 30.19
  • GRCE 0.00

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: